Recurrence of hepatitis C virus genotype-4 infection following orthotopic liver transplantation: Natural history and predictors of outcome

Annals of Saudi Medicine

Volumn 29, Issue 2, 2009, Pages 91-97

  Mudawi, Hatim ^a   Helmy, Ahmed ^a   Kamel, Yasser ^a   Al Saghier, Mohammed ^a   Al Sofayan, Mohammed ^a   Al Sebayel, Mohammed ^a   Khalaf, Hatem ^a   Al Bahili, Hamad ^a   Al Shiek, Yasser ^a   Alawi, Khalil ^a   AlJedai, Ahmed ^a   Mohamed, Hazem ^a   Al Hamoudi, Waleed ^a,b   Abdo, Ayman ^a,b  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PEGINTERFERON ALPHA2A; RIBAVIRIN; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CADAVER DONOR; DISEASE SEVERITY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT INFECTION; SURVIVAL RATE; ANALYSIS OF VARIANCE; CHI SQUARE DISTRIBUTION; GENETICS; GRAFT REJECTION; IMMUNOLOGY; MIDDLE AGED; NONPARAMETRIC TEST; RECURRENT DISEASE; SAUDI ARABIA; SURVIVAL; VIROLOGY; VIRUS LOAD;

ADULT; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; FEMALE; GENOTYPE; GRAFT REJECTION; HEPACIVIRUS; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RECURRENCE; SAUDI ARABIA; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; VIRAL LOAD;

EID: 68949137102     PISSN: 02564947     EISSN: 13199226     Source Type: Journal    
DOI: 10.4103/0256-4947.51796     Document Type: Article

References (21)

1. Terrault N, Berenguer M. Treating hepatitis C infection in liver transplant recipients. Liver Transpl. 2006:12:1192-1204.
2. Berenguer M, Prieto M, Rayón JM, Mora J, Pastor M, Ortiz V, Carrasco D, San Juan F, Burgueño MD, Mir J, Berenguer J. Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation. Hepatol. 2000 Oct;32(4 Pt 1):852-8.
3. Wali MH, Heydtmann M, Harrison RF, Gunson BK, Mutimer DJ. Outcome of liver transplantation for patients infected by hepatitis C, including those infected by genotype 4. Liver Transpl. 2003;9:796-804.
4. Gane E, Portmann B, Naoumov N, Smith H, Underhill JA, Donaldson O, Maertens G, Williams R. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med. 1996;20:773-779.
5. Zekry A, Whiting P, Crawford D, Angus P, Jeffrey G, Padbury R, et al. Liver transplantation for HCV associated liver cirrhosis: predictors of outcomes in a population with significant genotype 3 and 4 distribution. Liver Transpl. 2003;9:339-347.
6. Sugo H, Balderson GA, Crawford DH, Fawcett J, Lynch SV, Strong RW, Futagawa S. The influence of viral genotypes and rejection episodes on the recurrence of hepatitis C after liver transplantation. Surg Today. 2003;33:421-425.
7. Bedossa P, Poynard T. An algorithm for grading activity in chronic hepatitis C. Hepatol. 1996;24:289-293.
8. Al Sebayel M, Ramirez C, Abou Ella K. The first 100 liver transplants in Saudi Arabia. Transplant Proc. 2001;33:2709.
9. Al-Faleh FZ, Huraib S, Sbeih F, Al-Karawi M, Al-Rashed R, Al-Mofleh IA, Sougiyyah M, Shaheen M, Ramia S. Hepatitis C virus genotypes in patients with chronic liver disease and haemodialysis patients from Saudi Arabia. J Viral Hepat. 1995;2(6):293-296.
10. Osoba AO. Hepatitis C virus genotypes in Saudi Arabia. Saudi Med J. 2002;23:7-12.
11. Bukh J, Miller RH, Purcell RH. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis. 1995;15:41-63.
12. Féray C, Gigou M, Samuel D, Paradis V, Mishiro S, Maertens G, Reynés M, Okamoto H, Bismuth H, Bréchot C. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterol. 1995 Apr;108(4):1088-96.
13. Zhou S, Terrault NA, Ferrell L, Hahn JA, Lau JY, Simmonds P, Roberts JP, Lake JR, Ascher NL, Wright TL. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. Hepatol. 1996 Nov;24(5):1041-6.
14. Gordon FD, Poterucha JJ, Germer J, Zein NN, Batts KP, Gross JB Jr, Wiesner R, Persing D. Relationship between hepatitis C genotype and severity of recurrent hepatitis C after liver transplantation. Transplant. 1997 May 27;63(10):1419-23.
15. Wali M, Harrison R, Grow P, Mutimer D. Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C. Gut. 2002;51:248-252.
16. Lake J, Shorr J, Steffen B, Chu A, Gordon R, Wiesner R. Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C, and other viral hepatitis: Am J Transplant. 2005,5:549-557.
17. Berenguer M, Ferrell L, Watson J, Prieto M, Kim M, Rayón M, Córdoba J, Herola A, Ascher N, Mir J, Berenguer J, Wright TL HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol. 2000 Apr;32(4):673-84.
18. Charlton M, Seaberg E, Wiesner R, Everhart J, Zetterman R, Lake J, Detre K, Hoofnagle J. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatol. 1998 Sep;28(3):823-30.
19. Picciotto F, Tritto G, Lanza A, Addario L, De Lauca M, Di Costanzo G. Sustained virological response to antiviral therapy reduces mortality in HCV reinfection after liver transplantation. J Hepatol. 2007,46:459-65.
20. Lawal A, Ghobrial R, Te H, Artinian L, Eastwood D, Schiano TD. Comparison of hepatitis C histological recurrence rates and patient survival between split and deceased donor liver transplantation. Transplant Proc. 2007;39:3261-3265.
21. Schmeding M, Neumann UP, Puhl G, Bahra M, Neuhaus R, Neuhaus P. Hepatitis C recurrence and fibrosis progression are not increased after living donor liver transplantation: a single-center study of 289 patients. Liver Transpl. 2007;13:687-692.